Rep. Bruce Westerman

Essential Caregivers Act of 2025   This bill prohibits certain health care facilities from limiting the access of essential caregivers to residents of those facilities, including during designated emergency periods.   Specifically, the bill generally prohibits Medicare skilled nursing facilities, Medicaid nursing facilities, Medicaid intermediate care facilities, and associated inpatient rehabilitation facilities from restricting the access of essential caregivers to residents of the facilities, including during emergency periods in which visitation rights are otherwise restricted. During emergency periods, facilities may restrict access for an initial period of up to seven days and for one additional maximum seven-day period (if the additional period is approved by the state health department). Facilities may restrict access for a total of 7 days (or 14 days with the approval of the state health department) during an emergency period. Essential caregivers must agree to comply with any safety protocols set by the facility, which may be no more stringent for caregivers compared to those for staff. Caregivers who fail to comply with these requirements may be denied access, subject to an appeals process.

Miracle on Ice Congressional Gold Medal Act This act provides for the award of Congressional Gold Medals to the members of the 1980 U.S. Olympic men's ice hockey team in recognition of the team's achievement at the 1980 Winter Olympic Games.

Maddy summaryThis bill establishes new requirements for pharmacy benefit managers (PBMs) working with Medicare Part D prescription drug plans and Medicaid programs. It mandates that PBMs pay pharmacies a specific reimbursement amount based on drug acquisition costs plus a fixed fee, pass through manufacturer rebates directly to beneficiaries at the point of sale, and prohibits steering practices that direct patients to specific pharmacies. The bill applies to Medicare Part D plans and Medicaid managed care organizations beginning January 1, 2027, affecting how PBMs interact with pharmacies and handle drug rebates. Violations could result in criminal penalties of up to $1 million or 10 years in prison for willful noncompliance. The bill aims to increase transparency and fairness in pharmacy drug pricing for Medicare and Medicaid beneficiaries.

Maddy summaryThe Rx ACCESS Act improves prescription drug access for TRICARE beneficiaries, including military service members, retirees, and their families, by establishing fair reimbursement standards for pharmacies and expanding medication choice. It requires pharmacies to be reimbursed at actual drug costs (or the national average drug cost for certain medications) plus a standard dispensing fee, while banning hidden fees like point-of-sale charges. Starting October 1, 2026, beneficiaries can choose how they receive non-generic medications for ongoing health conditions. The law also mandates annual audits to verify reimbursement fairness and ensure pharmacy networks provide accessible care, especially in rural and underserved areas.

Maddy summaryThis bill suspends payment limits for agricultural subsidies for the 2025 crop year, removing caps on payments to farmers. It also establishes a new option for farmers to receive 50% of their expected 2025 crop payments as an advance by December 1, 2025, if they opt in. The remaining balance is paid later after the marketing year ends, with farmers required to repay any overpayment if the final amount exceeds the advance. The bill directly affects farmers growing covered commodities (like corn, soybeans) who choose to participate in the advance payment program.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Maddy summaryThe BUILD Act creates a federal grant program to support economic development in low-income communities through partnerships with qualifying colleges and universities. It provides planning grants (up to $100,000 annually for 2 years) to help institutions develop community revitalization plans, followed by implementation grants ($25-50 million over 5 years) for approved projects. Eligible projects include renovating community-accessible facilities (like housing, cultural centers, or health clinics), launching business incubators, creating local apprenticeships, and building public broadband networks. To qualify, institutions must be located in areas where median income is at least 25% below state or national averages, excluding high-research universities and military academies.

Maddy summaryHR 5563, the DRIVE-SAFE Act, creates a structured apprenticeship program for commercial drivers under age 21. It requires employers to provide a two-phase training program: a 120-hour probationary period focused on basic driving skills (like traffic navigation and safety awareness), followed by a 280-hour period covering advanced tasks (such as pre-trip inspections and load management). During both phases, apprentices must operate vehicles equipped with automatic transmissions, collision mitigation systems, and video capture, and must be accompanied by an experienced driver (26+ years old with no recent accidents or violations). The bill does not change existing commercial driver’s license requirements and mandates employers to maintain records and provide remediation for preventable accidents or violations during training.

Student Compensation and Opportunity through Rights and Endorsements Act or the SCORE Act This bill provides a framework for the compensation of student athletes for the use of their name, image, or likeness (NIL). This includes addressing certain elements of the court approved agreement to settle the In re College Athlete NIL Litigation (i.e., House settlement ). Specifically, the bill statutorily prohibits institutions, conferences, or interstate intercollegiate athletic associations (e.g., the National Collegiate Athletic Association (NCAA)) from restricting the ability of a student athlete to enter an NIL agreement. The bill also requires institutions of higher education that generate $20 million or more in annual revenue from the institution's intercollegiate athletics activities to (1) provide counseling and medical benefits to student athletes, and (2) establish and maintain at least 16 varsity sports teams. Further, the bill authorizes interstate intercollegiate athletic associations to establish rules with respect to athletic eligibility, transfers, recruitment, and the disclosure of NIL agreements. Under the bill, student athletes may not be considered employees of an institution, conference, or interstate intercollegiate athletic association. The bill also preempts state laws with respect to compensation, payments, benefits, employment status, eligibility, and academic standards applicable to student athletes. Compliance with the provisions of this bill is considered lawful under federal and state antitrust laws.

Maddy summaryHR 6167, the HEALTH Act of 2025, creates a new tax deduction for physicians providing unreimbursed charity care to patients enrolled in Medicaid (Title XIX) or CHIP (Title XXI) programs. The deduction equals the Medicare fee schedule amount for such care, but excludes services like sex reassignment surgeries and hormone treatments for gender transition. Additionally, the bill adds liability protection for physicians providing this charity care, shielding them from civil lawsuits for non-intentional harm during such services, and preempts conflicting state laws. This directly affects physicians who serve low-income patients through public health programs.